Valuation: aXichem AB

Market Cap 117M 11.95M 10.35M 9.79M 8.86M 16.64M 1.15B 16.76M 44.95M 581M 44.9M 43.9M 1.85B P/E 2024
-2.93x
P/E 2025 -6.9x
Enterprise Value 118M 12.12M 10.5M 9.93M 8.99M 16.87M 1.16B 17M 45.58M 590M 45.53M 44.52M 1.88B EV / Sales 2024
7.67x
EV / Sales 2025 6.72x
Free-Float
82.56%
Yield 2024 *
-
Yield 2025 -
1 day-6.25%
1 week-5.74%
Current month-14.60%
1 month-39.90%
3 months+31.18%
6 months+35.29%
Current year-16.67%
1 week 1.7
Extreme 1.7
1.96
1 month 1.7
Extreme 1.7
2.98
Current year 1.14
Extreme 1.135
4
1 year 1.14
Extreme 1.135
4
3 years 0.9
Extreme 0.898
15.5
5 years 0.9
Extreme 0.898
30.8
10 years 0.9
Extreme 0.898
95.8
Manager TitleAgeSince
Chief Executive Officer 69 31/12/2015
Chief Operating Officer 51 15/04/2025
Investor Relations Contact 64 31/12/2014
Director TitleAgeSince
Chairman 69 05/07/2007
Chairman 80 31/12/2016
Director/Board Member 77 31/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
28/03/24 Exercice

Director

33,602 0.1563%
28/03/24 Exercice

Director

134,408 0.6253%
27/03/24 Buy

Founder

200,000 0.9304%
Change 5-day change 1-year change 3-year change Capi.($)
-6.25%-5.74%-44.35%-75.64% 12.76M
-0.23%-1.72%+6.83%+42.70% 30.89B
-0.92%-7.29%-30.68%-33.15% 4.07B
-0.14%-4.58%-29.90%-6.42% 1.56B
+2.47%+2.82%-7.78%-12.85% 593M
+0.44%-2.50%-7.26%-23.50% 592M
+1.39%-0.95%-23.63%+90.81% 88.09M
-1.34%+2.03% - - 62.13M
Average -0.57%-0.58%-19.54%-2.58% 4.73B
Weighted average by Cap. -0.25%-2.02%+0.74%+30.68%

Financials

2024 2025
Net sales 8.57M 877K 759K 718K 650K 1.22M 84.1M 1.23M 3.3M 42.65M 3.29M 3.22M 136M 18.45M 1.89M 1.63M 1.55M 1.4M 2.63M 181M 2.65M 7.1M 91.79M 7.09M 6.93M 293M
Net income -17.81M -1.82M -1.58M -1.49M -1.35M -2.54M -175M -2.56M -6.85M -88.64M -6.85M -6.69M -283M -17.63M -1.8M -1.56M -1.48M -1.34M -2.51M -173M -2.53M -6.78M -87.74M -6.78M -6.63M -280M
Net Debt -14.36M -1.47M -1.27M -1.2M -1.09M -2.04M -141M -2.06M -5.52M -71.45M -5.52M -5.4M -228M 1.64M 168K 146K 138K 125K 234K 16.13M 236K 632K 8.18M 632K 618K 26.09M
Logo aXichem AB
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compant’s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).
Employees
7
Date Price Change Volume
15/09/26 SEK 1.725 -6.25% 86,737
14/09/26 SEK 1.840 +0.82% 170,158
11/09/26 SEK 1.825 0.00% 178,321
10/09/26 SEK 1.825 +1.11% 247,992
09/09/26 SEK 1.805 -4.75% 62,912
  1. Stock Market
  2. Stocks
  3. AXIC A Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!